Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) Holdings, has agreed to invest approximately $27.2m in Inogen, ...

INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D collaboration and accelerate the entry of Inogen's brand into the Chinese market.

After more than two decades of being primarily known for exclusively selling one product, portable oxygen containers, Goleta-based Inogen has spent the last couple of years branching out. That is ...

Needham analyst Michael Matson has maintained their neutral stance on INGN stock, giving a Hold rating on January 14.Invest with Confidence: ...

This raises our optimism about the stock. In October 2024, Inogen commenced the U.S. market release of the Rove 4 Portable Oxygen Concentrator (POC). This is likely to have witnessed a robust product ...

On the eve of theArab Health Exhibition Yuwell Medical held its 2025 Global Core Partner Conference in Dubai and announced a ...

More on INGN’s Robust Product Portfolio Inogen’s expanding product portfolio is a significant driver of its growth. It offers a range of oxygen concentrator solutions for both portable and ...

GOLETA, Calif. – Inogen has entered into a strategic collaboration with Jiangsu Yutue Medical Equipment & Supply Co. (Yuwell) to broaden its product portfolio through distribution of certain ...

GOLETA, Calif., January 26, 2025--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today ...

The 50th Arab Health Exhibition opened on Monday at the Dubai World Trade Center featuring over 4000 exhibitors from various countries including mo ...